Human endostatin inhibits growth of huma
β
Arnd Steffen Boehle; Roland Kurdow; Maren Schulze; Ursula Kliche; Bence Sipos; K
π
Article
π
2001
π
John Wiley and Sons
π
French
β 261 KB
π 1 views
Overall prognosis in human NSCLC remains poor. Antiangiogenic treatment has become a promising concept for the treatment of solid malignancies. Our purpose was to evaluate the efficacy of recombinant HSENDO for the treatment of human NSCLC in an orthotopic murine xenotransplantation model. The effic